US Stock MarketDetailed Quotes
ARDS Aridis Pharmaceuticals
- 0.000
- +0.000+9900.00%
15min DelayClose Dec 20 16:00 ET
4.46KMarket Cap0.00P/E (TTM)
0.000High0.000Low27.17KVolume0.000Open0.000Pre Close2.72Turnover0.07%Turnover Ratio0.00P/E (Static)44.57MShares0.09352wk High0.00P/B3.80KFloat Cap0.00052wk Low--Dividend TTM37.96MShs Float13.850Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About Aridis Pharmaceuticals Company
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Company Profile
SymbolARDS
Company NameAridis Pharmaceuticals
Listing DateAug 14, 2018
Issue Price13.00
Founded2014
CEODr. Vu Truong, PhD
MarketPink Market
Employees37
Fiscal Year Ends12-31
Address983 University Avenue,Building B
CityLos Gatos
ProvinceCalifornia
CountryUnited States of America
Zip Code95032
Phone1-408-385-1742
Websitehttp://www.aridispharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Vu Truong, PhD
- Director, Chief Executive Officer and Chief Scientific Officer
- --
- Dr. Hasan Jafri
- Chief Medical Officer
- --
- Fred Kurland
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Eric Patzer, PhD
- Executive Chairman of the Board
- --
- John F. Hamilton
- Independent Director
- --
- Dr. Susan Richards Windham-Bannister, PhD
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
